Vitiligo Treatments: Therapeutic Modalities and JAK Inhibitors Vitiligo Treatments: Therapeutic Modalities and JAK Inhibitors

Review current understanding of the major mechanisms involved in the pathogenesis of vitiligo and its most common available treatments, with a focus on the newly approved JAK1 and JAK2 inhibitors.American Journal of Clinical Dermatology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news
More News: Dermatology | Health | Skin | Vitiligo